Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits

Acta Cytologica

Volumn 45, Issue 6, 2001, Pages 919-926

  Menezes, G ^a   Euscher, E ^a   Schwartz, B ^a   Catania, F ^a   Chancellor, J ^a   Nuovo, G J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Hybridization; In situ; Papanicolaou smear; Papillomaviruses, human; Quality control

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING TEST; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0035197264     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000328364     Document Type: Article

References (18)

1. The role of human papillomavirus in gynecological diseases
2. Contemporary theories of cervical carcinogenesis: The virus, the host, and the stem cell
3. Human papillomavirus testing in women with mild cytologic atypia
4. Detection of human papillomavirus in Papanicolaou smears: Correlation with pathologic findings and clinical outcome
5. Molecular detection of human papillomavirus in women with minor-grade cervical cytology abnormalities
6. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of a typical cells of undetermined significance
7. Human papillomavirus DNA in situ hybridization may be used for the quality control of genital tract biopsies
8. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy proven cervical intraepithelial lesions
9. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
10. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in-situ
11. Human papillomavirus detection by the Hybrid Capture II assay: A reliable test to select women with normal cervical smears at risk for developing cervical lesions
12. HPV DNA in genital tract lesions histologically negative for condylomata: Analyses by in situ, Southern blot hybridization and the polymerase chain reaction
13. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction
14. Human papillomavirus detection in cervical lesions nondiagnostic for intraepithelial neoplasia: Correlation with Papanicolaou smear, colposcopy, and the occurrence of cervical intraepithelial neoplasia
15. Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types
16. HPV DNA testing of the residual sample of liquid based Pap test: Utility as a quality assurance monitor